Dissecting Integrin Expression and Function on Memory B Cells in Mice and Humans in Autoimmunity

Alessandro Camponeschi(University of Gothenburg), Natalija Gerasimčik(University of Gothenburg), Ying Wang(University of Gothenburg), Timothy Fredriksson(University of Gothenburg), Dong-Feng Chen(University of Gothenburg), Chiara Farroni(Bambino Gesù Children's Hospital), Katrin Thorarinsdottir(University of Gothenburg), Louise Sjökvist Ottsjö(University of Gothenburg), Alaitz Aranburu(University of Gothenburg), Susanna Cardell(University of Gothenburg), Rita Carsetti(Bambino Gesù Children's Hospital), Inger Gjertsson(University of Gothenburg), Inga‐Lill Mårtensson(University of Gothenburg), Ola Grimsholm(University of Gothenburg)
Frontiers in Immunology
March 21, 2019
Cited by 22Open Access
Full Text

Abstract

Immunological memory ensures life-long protection against previously encountered pathogens, and in mice and humans the spleen is an important reservoir for long-lived memory B cells (MBCs). It is well established that integrins play several crucial roles in lymphocyte survival and trafficking, but their involvement in the retention of MBCs in secondary lymphoid organs, and differences between B cell subsets in their adhesion capacity to ICAM-1 and/or VCAM-1 have not yet been confirmed. Here, we use an autoimmune mouse model, where MBCs are abundant, to show that the highest levels of LFA-1 and VLA-4 amongst B cells are found on MBCs. In vivo blockade of VLA-4 alone or in combination with LFA-1, but not LFA-1 alone, causes a release of MBCs from the spleen into the blood stream. In humans, we find that in peripheral blood, spleens and tonsils from healthy donors the highest expression levels of the integrins LFA-1 and VLA-4 are also found on MBCs. Consistent with this, we found MBCs to have a higher capacity to adhere to ICAM-1 and VCAM-1 than naïve B cells. In patients with the autoimmune disease rheumatoid arthritis, it is the MBCs that have the highest levels of LFA-1 and VLA-4; moreover, compared with healthy donors, naïve B and MBCs of patients receiving anti-TNF medication have enhanced levels of the active form of LFA-1. Commensurate levels of the active L subunit can be induced on B cells from healthy donors by exposure to the integrin ligands. Thus, our findings establish the selective use of the integrins LFA-1 and VLA-4 in the localization and adhesion of MBCs in both mice and humans.


Related Papers

No related papers found

Powered by citation graph analysis